首页> 美国卫生研究院文献>American Journal of Physiology - Regulatory Integrative and Comparative Physiology >Mitochondrial Function/Dysfunction in Health and Disease: Local delivery of a PKCε-activating peptide limits ischemia reperfusion injury in the aged female rat heart
【2h】

Mitochondrial Function/Dysfunction in Health and Disease: Local delivery of a PKCε-activating peptide limits ischemia reperfusion injury in the aged female rat heart

机译:线粒体功能/功能障碍在健康与疾病中的作用:PKCε激活肽的局部递送限制了老年雌性大鼠心脏的缺血再灌注损伤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Reduced efficacy of cardioprotective interventions in the aged female heart, including estrogen replacement, highlights the need for alternative therapeutics to reduce myocardial ischemia-reperfusion (I/R) injury in postmenopausal women. Here, we sought to determine the efficacy of protein kinase-Cε (PKCε)-mediated cardioprotection in the aged, estradiol-deficient rat heart. Infarct size and functional recovery were assessed in Langendorff-perfused hearts from adult (5 mo) or aged (23 mo) female Fisher 344 ovary-intact or ovariectomized (OVX) rats administered a PKCε-activator, receptor for activated C kinase (ψεRACK) prior to 47-min ischemia and 60-min reperfusion. Proteomic analysis was conducted on left ventricular mitochondrial fractions treated with ψεRACK prior to I/R, utilizing isobaric tags for relative and absolute quantitation (iTRAQ) 8plex labeling and tandem mass spectrometry. Real-time PCR was utilized to assess connexin 43 (Cx43) and RACK2 mRNA post-I/R. Greater infarct size in aged OVX (78%) vs. adult (37%) was reduced by ψεRACK (35%, P < 0.0001) and associated with greater mitochondrial PKCε localization (P < 0.0003). Proteomic analysis revealed three novel mitochondrial targets of PKCε-mediated cardioprotection with aging (P < 0.05): the antioxidant enzymes glutathione peroxidase (GPX) and MnSOD2, and heat shock protein 10. Finally, decreased levels of Cx43 and RACK2 mRNA seen with age were partially abrogated by administration of ψεRACK (P < 0.05). The mechanisms described here may represent important therapeutic candidates for the treatment of acute myocardial infarction in postmenopausal women and age-associated estradiol deficiency.
机译:老年女性心脏的心脏保护性干预措施(包括雌激素替代治疗)的疗效降低,凸显了对减少绝经后女性心肌缺血再灌注(I / R)损伤的替代疗法的需求。在这里,我们试图确定蛋白激酶-Cε(PKCε)介导的老年雌二醇缺乏大鼠心脏心脏保护的功效。在成年(5 mo)或老年(23 mo)雌性Fisher 344卵巢完整或卵巢切除(OVX)大鼠中,给予PKCε-激活剂,活化C激酶受体(ψεRACK),评估Langendorff灌注心脏的梗塞面积和功能恢复缺血47分钟和再灌注60分钟之前。蛋白质组学分析是在I / R之前使用ψεRACK处理的左心室线粒体部分进行的,利用同量异位标记进行相对和绝对定量(iTRAQ)8plex标记和串联质谱分析。实时PCR用于评估连接蛋白43(Cx43)和I / R后的RACK2 mRNA。 εRACK(35%,P <0.0001)降低了老年OVX(78%)与成人(37%)的更大梗塞面积,并伴随着更大的线粒体PKCε定位(P <0.0003)。蛋白质组学分析揭示了PKCε介导的随年龄增长的线粒体保护作用的三个新靶点(P <0.05):抗氧化酶谷胱甘肽过氧化物酶(GPX)和MnSOD2,以及热休克蛋白10。最后,随着年龄的增长,Cx43和RACK2 mRNA水平下降通过施用ψεRACK可部分废除(P <0.05)。这里描述的机制可能代表了绝经后妇女和与年龄相关的雌二醇缺乏症的急性心肌梗死的重要治疗候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号